During the past decade, Martin Faculty Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Martin Faculty Hospital" are "Acute Ischemic Stroke" (1 trials), "Migraine" (1 trials), "Prostate Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Martin Faculty Hospital" in a lesser frequency.

Most popular intervention types in "Martin Faculty Hospital" are "Biological" (2 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (1 trials), "Endoxana, IMA901, Leukine" (1 trials), "Filgrastim" (1 trials), "IMA901 and Leukine" (1 trials) and "Sodium chloride solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Martin Faculty Hospital" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Martin Faculty Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Martin Faculty Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Martin Faculty Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".